genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
Coronavirus
COVID-19 Puts Spotlight on Artificial Intelligence
Data Management
VAST Ambition When It Comes To Data Storage
Antisense
NeuBase Sets a Course for the Clinic
News
Cancer
Cancer Immunotherapy Study Identifies New Checkpoint Targets in Myeloid Cells
Translational Medicine
p53’s Multiple Roles Are Acquired during Pluripotent Stem Cell Differentiation
Drug Discovery
Ketamine’s Antidepressant Activity Examined at Brain Receptor Level
Coronavirus
SARS-CoV-2 Likely Entered New York City from European and U.S. Sources
Infectious Diseases
New Recombineering Method May Overcome Key Obstacle in Genetically Engineering Bacteria
Insights
All
Trends for 2020
Bioprocessing
COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
Bioprocessing
Decreasing the Time from Antibody Idea to IND Approval
Bioprocessing
Introducing New Bioprocessing Technologies in the Era of COVID-19
Bioprocessing
Smart AI Use Could Benefit Biopharma
A-Lists
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Cancer Immunotherapy Study Identifies New Checkpoint Targets in Myeloid Cells
Translational Medicine
p53’s Multiple Roles Are Acquired during Pluripotent Stem Cell Differentiation
Upcoming Webinars
Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation
Drug Discovery
Ketamine’s Antidepressant Activity Examined at Brain Receptor Level
Magazine
All
Supplement
Coronavirus
Race for a Coronavirus Vaccine
Drug Discovery
Protein Modulation Helps Drug Design Get a Grip
OMICs
Proteomic Mass Spec Assesses Biomolecular Teamwork
Coronavirus
COVID-19 Drives CRISPR Diagnostics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation
On Demand Webinars
Organoids and Spheroids Help Science See in 3D
Upcoming Webinars
A CRISPR Vision for the Future of Cell Therapy
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Oncologics
Oncologics
7 days popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Oncologics
DNA Repair Mechanism Aids Cancer by Mending Chemo Damage
Oncologics
Reputed Oncogene May Act as a Tumor Suppressor
Oncologics
Synthon, Sanquin Partner on Anticancer Antibodies Targeting CD47-SIRPalpha
Oncologics
Engineered Gut Bacteria Provide Enzyme That Helps Green Vegetables Fight Cancer
Oncologics
Winding Biological Clock Shortens Cancer’s Meal Time
Oncologics
Sosei Takes Stake in saRNA Therapeutics Firm MiNA with Option for...
Oncologics
Fully Autonomous DNA Nanorobots Target and Starve Tumors in Mice
Oncologics
Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines
Oncologics
Newly Uncovered Pathway Points to New Strategies Against Ovarian Cancer
Oncologics
Debiopharm Pays $25M Upfront for ImmunoGen’s Phase II Stage ADC for...
1
2
Page 1 of 2
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Mouse fed with the engineered microbe and a cruciferous vegetable-rich diet. [Chun-Loong Ho/The National University of Singapore]](https://www.genengnews.com/wp-content/uploads/2018/08/Jan11_2018_ChunLoongHo_RatBroccoli6510205243-324x160.jpg "Engineered Gut Bacteria Provide Enzyme That Helps Green Vegetables Fight Cancer")
